Similar effects were observed in the 5XFAD mouse model (Table 2), where Aβ-specific CD4+ TH1 cells abrogated AD-like pathology via a subpopulation of microglia that expressed the major histocompatibility complex class II (MHC II) [50]. Here, CD4 is linked to Alzheimer disease.